23 May 2013
Keywords: Covance, Collaboration, R&D, Inserm
Article | 12 January 2012
USA-based contract research organization Covance (NYSE: CVD) has signed a four-year scientific collaboration agreement for R&D with ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 January 2012
© 2013 thepharmaletter.com